全文获取类型
收费全文 | 17885篇 |
免费 | 2133篇 |
国内免费 | 300篇 |
专业分类
耳鼻咽喉 | 198篇 |
儿科学 | 2484篇 |
妇产科学 | 168篇 |
基础医学 | 1805篇 |
口腔科学 | 517篇 |
临床医学 | 2297篇 |
内科学 | 1610篇 |
皮肤病学 | 257篇 |
神经病学 | 3572篇 |
特种医学 | 275篇 |
外科学 | 845篇 |
综合类 | 1335篇 |
现状与发展 | 3篇 |
一般理论 | 3篇 |
预防医学 | 2716篇 |
眼科学 | 168篇 |
药学 | 700篇 |
13篇 | |
中国医学 | 495篇 |
肿瘤学 | 857篇 |
出版年
2024年 | 19篇 |
2023年 | 449篇 |
2022年 | 486篇 |
2021年 | 930篇 |
2020年 | 971篇 |
2019年 | 1013篇 |
2018年 | 963篇 |
2017年 | 881篇 |
2016年 | 782篇 |
2015年 | 728篇 |
2014年 | 1212篇 |
2013年 | 1560篇 |
2012年 | 1085篇 |
2011年 | 1025篇 |
2010年 | 742篇 |
2009年 | 810篇 |
2008年 | 776篇 |
2007年 | 719篇 |
2006年 | 616篇 |
2005年 | 512篇 |
2004年 | 468篇 |
2003年 | 411篇 |
2002年 | 385篇 |
2001年 | 315篇 |
2000年 | 273篇 |
1999年 | 201篇 |
1998年 | 214篇 |
1997年 | 162篇 |
1996年 | 164篇 |
1995年 | 148篇 |
1994年 | 145篇 |
1993年 | 152篇 |
1992年 | 99篇 |
1991年 | 104篇 |
1990年 | 82篇 |
1989年 | 88篇 |
1988年 | 82篇 |
1987年 | 74篇 |
1986年 | 57篇 |
1985年 | 70篇 |
1984年 | 60篇 |
1983年 | 36篇 |
1982年 | 48篇 |
1981年 | 33篇 |
1980年 | 27篇 |
1979年 | 39篇 |
1978年 | 29篇 |
1977年 | 17篇 |
1976年 | 20篇 |
1975年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Jana Kristin Eckert Julia Kahle Andreas Bck Kathrin Zeber Kathrin Urner Wolfgang Greiner Simone Kreimeier Kirsten Beyer Josefine Dobbertin-Welsch Eckard Hamelmann Ines Gellhaus Christina Schorlemer Michael Kabesch Parastoo Kheiroddin Erika von Mutius Martin Depner Daniel Walter Gesine Hansen Stephanie DeStefano Sabine Schnadt Bianca Schaub 《Pediatric allergy and immunology》2022,33(1):e13652
2.
3.
4.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(4):602-606
IntroductionThe Modena bleeding score is a categorical rating scale that allows the assessment of the surgical field in relation to bleeding during endoscopic surgery. It has recently been presented and validated in the field of endoscopic ear surgery by the present authors. The Modena bleeding score provides five grades for rating the surgical field during endoscopic procedures (from grade 1 ? no bleeding to grade 5 ? bleeding that prevents every surgical procedure except those dedicated to bleeding control).ObjectiveThe aim of this study was to validate the Modena bleeding score in the setting of endoscopic sinus surgery.MethodsFifteen three-minute videos of endoscopic sinus surgery procedures (each containing three bleeding situations) were evaluated by 15 specialists, using the Modena bleeding score. Intra and inter-rater reliability were assessed, and the clinical validity of the Modena bleeding score was calculated using a referent standard.ResultsThe data analysis showed an intra-rater reliability ranging from 0.6336 to 0.861. The inter-rater reliability ranged from 0.676 to 0.844. The clinical validity was α = 0.70; confidence limits: 0.64 ? 0.75, corresponding to substantial agreement.ConclusionThe Modena bleeding score is an effective method to score bleeding during endoscopic sinus surgery. Its application in future research could facilitate the performance and efficacy assessment of surgical techniques, materials or devices aimed to bleeding control during endoscopic sinus surgery. 相似文献
5.
6.
7.
8.
童年期不良经历(ACEs)作为一项全球性的严峻公共卫生挑战,其对全生命周期的健康影响不容小觑。因此本文从心理健康、生理健康、性传播疾病及危险性行为、健康危险行为4个方面对ACEs的健康影响进行综述,为ACEs及其可能健康结局提供参考。 相似文献
9.
10.
《Value in health》2022,25(2):178-184
ObjectivesThe ALIC4E trial has shown that oseltamivir reduces recovery time while increasing the risk of nausea. This secondary analysis of the ALIC4E trial aimed to determine the gain in quality-adjusted life-years (QALYs) associated with adding oseltamivir to usual primary care in patients presenting with influenza-like illness (ILI).MethodsPatients with ILI were recruited during the influenza season (2015-2018) in 15 European countries. Patients were assigned to usual care with or without oseltamivir through stratified randomization (age, severity, comorbidities, and symptom onset). Patients’ health status was valued with the EQ-5D and visual analog scale (VAS) for up to 28 days. Average EQ-5D and VAS scores over time were estimated for both treatment groups using one-inflated beta regression in children (<13 years old) and adults (≥13 years old). QALY gain was calculated as the difference between the groups. Sensitivity analysis considered the value set to convert EQ-5D answers to summary scores and the follow-up period.ResultsIn adults, oseltamivir gained 0.0006 (95% confidence interval 0.0002-0.0010) QALYs, whereas no statistically significant gain was found in children (14-day follow-up, EQ-5D). QALY gains were statistically significant in patients aged ≥65 years, patients without relevant comorbidities, or patients experiencing symptoms for ≤48 hours. Using VAS and accounting for 28-day follow-up resulted in higher QALY gain.ConclusionsQALY gain owing to oseltamivir is limited compared with other diseases, and its clinical meaningfulness remains to be determined. Further analysis is needed to evaluate whether QALY gain and its impact on ILI treatment cost render oseltamivir cost-effective. 相似文献